Anthony R. Tersigni, EdD, FACHE Nonprofit Catholic health system Ascension, one of the biggest in the country, has announced several key changes to its leadership. The changes will be effective on July 1. IMPACT The changes are as follows: Anthony R. Tersigni, will transition his responsibilities as Ascension CEO and will continue to serve Ascension… Read More »
INVERTO, Boston Consulting Group’s procurement focused subsidiary, is expanding its UK presence as companies continue to manage growth, economic uncertainty and supply chain disruption LONDON, 8 March – INVERTO, one of Europe’s leading procurement and supply chain management consultancies, and a subsidiary of Boston Consulting Group (BCG), is announcing UK expansion plans to help companies… Read More »
Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »
Print this page DUBLIN–(BUSINESS WIRE)–Dec. 27, 2018– Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to expand the age range for Ravicti (glycerol phenylbutyrate) Oral Liquid to include infants younger than two months of age living with a urea cycle disorder… Read More »
Duffaut will drive company’s continued growth as it moves towards a platform and subscription-based business London, UK – December 20, 2018, Finastra has appointed Eric Duffaut as President and Global Head of Field Operations. Based at Finastra’s London Headquarters, Duffaut will take responsibility for the company’s entire go-to-market organization including global sales, services and consultancy,… Read More »